Max Colbert Md, Mba Email & Phone Number

New York, Ny, Us

New York, New York, Us

• Leading business development and marketing initiatives for AI-based diagnostic device startup• Prepared full business plan including investment thesis, go-to-market and growth strategies, exit opportunities, market and competitor analyses, and financial modeling• Recruited prominent key opinion leaders from target market segments to serve on medical advisory board and interface with these KOLs frequently • Engaged with target investment firms, prepared due diligence materials, and contributed to efforts to successfully raise several million dollars in early-stage capital• Drafted NIH and NSF grant applications to support the development of our novel technology• Co-inventor on multiple pending patent applications for AI-powered diagnostic device

New York, Ny, Us

Boston, Ma, Us

• Responsible for research planning and coordination for clinical stage laser surgical device startup, commercializing the market’s first intervention which truly restores youthful vision in presbyopes• Orchestrated a collaborative, multinational research study investigating new indication for device in the drug delivery space• Lead author on several published trade journal articles describing the complex processes of physiologic accommodation, presbyopia progression, and the theory underlying Ace Vision Group’s revolutionary intervention• Speaker and instructor in medical advisory board meetings at prominent international medical conferences

Newport Beach, California, Us

• Conducted due diligence, primary research, financial statement analysis, and generated investment theses regarding potential new investments, including therapeutics, diagnostic imaging, biotech, and medical devices• Worked closely with existing portfolio companies to navigate regulatory, clinical, and operational challenges• Developed marketing material and financial models for portfolio company preparing for a Series C financing• Performed extensive market research to identify, spoke with key opinion leaders, and perform valuation of potential acquisition targets for a publicly traded pharmaceutical company

• Studied the neurodegenerative effects of glaucoma using higher order MRI-based imaging modalities, such as fMRI and diffusion kurtosis imaging• Investigated a new therapeutic medical device posited to restore vision in glaucoma by deploying alternating current electrical stimulation transorbitally• Recruited 100+ patients to participate in world’s largest MRI glaucoma study analyzing mechanisms of glaucomatous neurodegeneration• Outcomes: Two lectures at major academic conferences, two prestigious research awards, one first-author manuscript in a top ophthalmology journal, and two co-authored peer-reviewed manuscripts

Bethesda, Md, Us

• Pre-clinical drug development of new biologic pharmacotherapy increasing longitudinal bone growth by 10% in mice with achondroplasia, with attention to pharmacodynamics/pharmacokinetics, and tissue distribution• Created a fusion protein combining IGF1 and anti-matrilin-3 antibody, to target drug delivery specifically to growth plates and avoid off-target effects of IGF1• Designed a novel approach to evaluate drug delivery to growth plate utilizing radiolabeled proteins and trained many colleagues in this technique • Outcomes: One peer-reviewed manuscript in press

Tallahassee, Fl, Us

• Conducted molecular biology, pharmacokinetics and pharmakodynamics, and literature review to elucidate biochemical mechanisms underlying initiation of DNA replication in eukaryotes• Elucidated the specific biochemical processes producing the assembly and activation of replication fork helicase complex, governed by 2 S-phase specific kinases• Outcomes: Two peer-reviewed manuscripts in press

Doctor Of Medicine - Md

Master Of Business Administration - Mba

Bachelor Of Science - Bs, Biological And Biomedical Sciences